PIP-AMITRIPTYLINE amitriptyline hydrochloride 50mg tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

amitriptyline hydrochloride, Quantity: 50 mg

Disponible depuis:

Ipca Pharma (Australia) Pty Ltd

DCI (Dénomination commune internationale):

amitriptyline hydrochloride

forme pharmaceutique:

Tablet

Composition:

Excipient Ingredients: purified talc; hypromellose; macrogol 6000; sunset yellow FCF aluminium lake; microcrystalline cellulose; lactose monohydrate; titanium dioxide; crospovidone; maize starch; magnesium stearate; colloidal anhydrous silica; indigo carmine aluminium lake

Mode d'administration:

Oral

Unités en paquet:

20, 50 and 100

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

For the treatment of major depression. Amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,Nocturnal enuresis where organic pathology has been excluded.

Descriptif du produit:

Visual Identification: Brown colour, circular, biconvex, film coated tablets with 'IA' over '50' debossed on one side and plain on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Licence status A

Date de l'autorisation:

2014-08-22